Sijuan Ding
Yongzhou, 425002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Integrated network pharmacology, molecular docking, and experimental validation reveal synergistic inhibition of EGFR and PI3K-Akt/JAK2-STAT3 pathways by Esculin and Esculetin to exert anti-colorectal cancer effects.
Journal: Toxicology and applied pharmacology
Published: June 10, 2026
Fovinaciclib for First-Line Therapy of Advanced Breast Cancer: A Randomized Clinical Trial.
Journal: JAMA oncology
Published: June 01, 2026
Machine learning and cox model-based prediction of CDK4/6 inhibitor outcomes in HR+/HER2 - metastatic breast cancer: a multicenter real-world study.
Journal: Breast cancer research and treatment
Published: March 15, 2026
Tibremciclib or Placebo Plus Fulvestrant in Hormone Receptor-Positive and ERBB2-Negative Advanced Breast Cancer After Endocrine Therapy: A Randomized Clinical Trial.
Journal: JAMA oncology
Published: July 31, 2025
CES3 promotes NSCLC progression via lipid metabolic reprogramming regulated by TFAP2A.
Journal: Journal of Cancer
Published: May 28, 2025
Treatment beyond progression and rechallenge with pyrotinib in HER2-positive metastatic breast cancer and brain metastases: a multicenter real-world study.
Journal: Therapeutic advances in medical oncology
Published: May 16, 2025
Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy for locally advanced cervical cancer: a multicenter real-world study.
Journal: Scientific reports
Published: January 27, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial.
Journal: Signal transduction and targeted therapy
Published: January 18, 2025
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial.
Journal: Journal for immunotherapy of cancer
Published: December 30, 2024
Survival outcomes and safety of nimotuzumab combined with radiotherapy ± chemotherapy for locally advanced cervical cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 23, 2024
Last Updated: 09/26/2026